BSX · NYSE · CIK 0000885725

BOSTON SCIENTIFIC CORP

BOSTON SCIENTIFIC CORP’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 7, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $20.1B and net income of $2.9B, according to its XBRL data on EDGAR. Its EDGAR record lists 56 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$20.1B
Net income, FY2025
$2.9B
Form 4 filings on record, past 12 months
56

Company overview

Legal name (as filed)
BOSTON SCIENTIFIC CORP
Ticker
BSX
SEC Central Index Key (CIK)
0000885725
Business address
MARLBOROUGH, MA
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#256 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from BOSTON SCIENTIFIC CORP’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$11.9BFY2021$12.7BFY2022$14.2BFY2023$16.7BFY2024$20.1BFY2025
Net income
$1.0BFY2021$698.0MFY2022$1.6BFY2023$1.8BFY2024$2.9BFY2025
BSX annual results
ItemFY2021
ended Dec 31, 2021
FY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$11.9B$12.7B$14.2B$16.7B$20.1B
Net income$1.0B$698.0M$1.6B$1.8B$2.9B
Diluted EPS$0.69$0.45$1.07$1.25$1.94
Total assets$32.2B$32.5B$35.1B$39.4B$43.7B
Cash and equivalents$1.9B$928.0M$865.0M$414.0M$2.0B

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = ProfitLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

BSX latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 17, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 3, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 7, 20268-KDirector or officer change; Other events· period Oct 1, 2026Document · Index
Mar 18, 2026DEF 14ADefinitive proxy statement· period Mar 18, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about BOSTON SCIENTIFIC CORP, by form type:

4 ×258-K ×9SCHEDULE 13G/A ×210-Q ×111-K ×1SD ×1S-8 ×1
BSX recent filings
FiledFormWhat it isOriginal
Oct 7, 20268-KDirector or officer change; Other events· period Oct 1, 2026Document · Index
Sep 23, 20268-KDirector or officer change· period Sep 21, 2026Document · Index
Sep 8, 20268-KCybersecurity incident· period Sep 7, 2026Document · Index
Sep 3, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 2, 2026Document · Index
Aug 26, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 25, 2026Document · Index
Aug 26, 20268-KOther events· period Aug 26, 2026Document · Index
Aug 12, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 11, 2026Document · Index
Aug 11, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 10, 2026Document · Index
Aug 7, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 5, 2026Document · Index
Aug 6, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 5, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 3, 2026Document · Index
Aug 5, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 3, 2026Document · Index
Aug 3, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026Document · Index
Aug 3, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026Document · Index
Aug 3, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 29, 20268-KResults of operations· period Jul 29, 2026Document · Index
Jul 27, 20268-KExit or disposal costs· period Jul 21, 2026Document · Index
Jul 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026Document · Index
Jun 24, 202611-KAnnual report of employee stock plans· period Dec 31, 2025Document · Index
Jun 1, 20264Statement of changes in beneficial ownership (insider trade)· period May 28, 2026Document · Index
May 21, 20264Statement of changes in beneficial ownership (insider trade)· period May 20, 2026Document · Index
May 21, 20264Statement of changes in beneficial ownership (insider trade)· period May 20, 2026Document · Index
May 21, 20264Statement of changes in beneficial ownership (insider trade)· period May 19, 2026Document · Index
May 21, 2026SDSpecialized disclosure report (conflict minerals)Document · Index
May 18, 20268-KOther events· period May 18, 2026Document · Index
May 18, 20268-KOther events· period May 18, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 8, 2026S-8Registration of employee benefit plan securitiesDocument · Index
May 6, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 5, 20268-KCharter, bylaws or fiscal year change; Shareholder vote results· period Apr 30, 2026Document · Index
May 4, 20264Statement of changes in beneficial ownership (insider trade)· period May 2, 2026Document · Index
May 4, 20264Statement of changes in beneficial ownership (insider trade)· period May 2, 2026Document · Index

Insider filing activity

56 Form 4 filings appear in BOSTON SCIENTIFIC CORP’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in Massachusetts

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000885725 and XBRL company facts. BOSTON SCIENTIFIC CORP on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.